476 G. Riedel and S.N. Davies
Satz P, Fletcher JM, Sutker LS (1976) Neuropsychologic, intellectual and personality corre-
lates in chronic marihuana use in native Costa Ricans. Ann NY Acad Sci 282:266–306
Schneider M, Koch M (2002) The cannabinoid agonist WIN 55,212–2 reduces sensorimotor
gating and recognition memory in rats. Behav Pharmacol 13:29–37
Schulze GE, McMillan DE, Bailey JR, et al (1988) Acute effects of delta-9-tetrahydrocannabi-
nol in rhesus monkeys as measured by performance in a battery of complex operant
tests. J Pharmacol Exp Ther 245:178–186
Schwartz RH, Gruenewald PJ, Klitzner M, et al (1989) Short-term memory impairments in
cannabis-dependent adolescents. Am J Dis Child 143:1214–1219
Schweitzer P, Siggins GR, Madamba SG (1999) Cannabinoid modulation of neuronal activity
in adult rat hippocampus. Adv Exp Med Biol 469:547–552
Sjöström PJ, Turrigano GG, Nelson SB (2003) Neocortical LTD via coincident activation of
presynaptic NMDA and cannabinoid receptors. Neuron 39:641–654
Solowij N (1998) Cannabis and cognitive functioning. Cambridge University Press, Cam-
bridge
Soueif MI (1976) Some determinant of psychological deficits associated with chronic
cannabis consumption. Bull Narc 28:25–42
Stadnicki SW, Schaeppi U, Rosenkrantz H, et al (1974) Crude marihuana extract: EEG and
behavioral effects of chronic oral administration in rhesus monkeys. Psychopharma-
cologia 37:225–233
Stella N, Schweitzer P, Piomelli D (1997) A second endogenous cannabinoid that modulates
long-term potentiation. Nature 388:773–778
StiglickA,KalantH(1982)Learningimpairmentintheradial-armmazefollowingprolonged
cannabis treatment in rats. Psychopharmacology (Berl) 77:117–123
Stiglick A, Llewellyn ME, Kalant H (1984) Residual effects of prolonged cannabis treatment
on shuttle-box avoidance in the rat. Psychopharmacology (Berl) 84:476–479
StrohmetzDB,AltermanAI,WalterD(1990)Subjectselectionbiasinalcoholicsvolunteering
for a treatment study. Alcohol Clin Exp Res 14:736–738
Struve FA, Straumanis JJ, Patrick G (1994) Persistent topographic quantitative EEG sequelae
of chronic marijuana use: A replication study and initial discriminant function analysis.
Clin Electroencephalogr 25:63–75
Szallasi A, Di Marzo V (2000) New perspectives on enigmatic vanilloid receptors. Trends
Neurosci 23:491–497
Tart CT (1971) On being stoned. Science and Behavior Books,Palo Alto
Teng AH, Craft RM (2004) CB1 receptor mediation of cannabinoid behavioural effects in
male and female rats. Psychopharmacology (Berl) 172:25–30
Terranova J-P, Michaud J-C, Le Fur G, Soubrie P (1995) Inhibition of long-term potentia-
tion in rat hippocampal slices by anandamide and WIN55,212-2: reversal by SR141716A,
a selective antagonist of CB1 cannabinoid receptors. Naunyn Schmiedebergs Arch Phar-
macol 352:576–579
Terranova J-P, Storme J-J, Lafon N, et al (1996) Improvement of memory in rodents by the
selective CB1 cannabinoid receptor antagonist, SR141716. Psychopharmacology (Berl)
126:165–172
Varma N, Carlson GC, Ledent C, Alger BE (2001) Metabotropic glutamate receptors drive
the endocannabinoid system in hippocampus. J Neurosci 21:RC188
Varvel SA, Lichtman AH (2002) Evaluation of CB1 receptor knockout mice in the Morris
water maze. J Pharmacol Exp Ther 301:915–924
Varvel SA, Hamm RJ, Martin BR, et al (2001) Differential effects of∆9THC on spatial
reference and working memory in mice. Psychopharmacology (Berl) 157:142–150
Westlake GA, Howlett AC, Bonner TI, Matsuda LA, Herkenham M (1994) Cannabinoid
receptor binding and messenger RNA expression in human brain: an in vitro recep-
tor autoradiography and in situ hybridization histochemistry study of normal and
Alzheimer’s brains. Neuroscience 63:637–652